Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Harkin Exit Intensifies Industry Need To Bolster Supplement Caucus

This article was originally published in The Tan Sheet

Executive Summary

One of DSHEA’s chief authors, Tom Harkin will retire from the Senate after 2014, pressuring supplement industry leaders to identify the next generation of congressional supporters. CRN’s Steve Mister says it will not be possible to replace the duo of Harkin and Orrin Hatch, who is retiring after 2018.

Advertisement

Related Content

Supplement Self-Regulation Key To Preventing More Oversight – Heinrich
New Mexico Sen. Heinrich Voices Supplement Industry Support
Senate HELP Leaders Harkin, Alexander Start Year With Teamwork
In Brief
FDA Revision Of NDI Draft Guidance Starts With Grandfathered List
Dietary Supplement Caucus Goes Bicameral, Adds Hatch, Harkin As Co-Chairs
McCain To Scrap Supplement Bill Support For Food Safety Reform Push
AER Bill Will Provide Documented History Of Supplement Safety – Industry

Topics

Advertisement
UsernamePublicRestriction

Register

PS106217

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel